Clinical Study
Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus
Table 2
Lifetime prevalence of illicit drugs use in 209 teenage patients with T1D compared with their healthy peers (
= 12114).
| | Stimulant | Subjects | Lifetime prevalence | | | DM1 (%) | C (%) |
| | Illicit drugs | All | 58 (28.2) | 5524 (46.1) | | |
15-16 years | 22 (23.0) | 2436 (40.7) | | |
17-18 years | 36 (33.0) | 3085 (51.4) | | | Boys | 32 (30.5) | 2893 (49.0) | | | Girls | 26 (25.7) | 2631 (43.3) | |
| | Marijuana/hashish | All | 38 (18.4) | 3976 (33.1) | | |
15-16 years | 12 (12.4) | 1587 (26.5) | | |
17-18 years | 26 (23.9) | 2387 (39.8) | | | Boys | 24 (22.6) | 2396 (40.5) | | | Girls | 14 (13.9) | 1580 (26) | |
| | Amphetamine | All | 8 (3.9) | 814 (6.8) | | |
15-16 years | 3 (3.1) | 295 (4.9) | | |
17-18 years | 5 (4.6) | 518 (8.6) | | | Boys | 7 (6.5) | 484 (8.2) | | | Girls | 1 (1.0) | 330 (5.4) | |
| | LSD and hallucinogens | All | 3 (1.4) | 473 (3.9) | | |
15-16 years | 1 (1.0) | 212 (3.5) | | |
17-18 years | 2 (1.8) | 260 (4.3) | | | Boys | 3 (2.8) | 289 (4.9) | | | Girls | 0 (0.0) | 184 (3.0) | |
| | Ecstasy | All | 1 (0.5) | 486 (4.0) | | |
15-16 years | 0 (0.0) | 209 (3.5) | | |
17-18 years | 1 (0.9) | 276 (4.6) | | | Boys | 1 (0.9) | 305 (5.1) | | | Girls | 0 (0.0) | 181 (3.0) | |
| | Magic mushrooms | All | 3 (1.4) | 428 (3.6) | | |
15-16 years | 0 (0.0) | 185 (3.1) | | |
17-18 years | 3 (2.8) | 242 (4.0) | | | Boys | 3 (2.8) | 301 (5.1) | | | Girls | 0 (0.0) | 127 (2.1) | |
| | Tranquillizers and sedatives | All | 20 (9.6) | 1911 (15.9) | | |
15-16 years | 8 (8.2) | 906 (15.1) | | |
17-18 years | 12 (11.0) | 1004 (16.7) | | | Boys | 7 (6.5) | 632 (10.6) | | | Girls | 13 (12.9) | 1279 (21.0) | |
| | Crack | All | 1 (0.5) | 237 (2.0) | | |
15-16 years | 1 (0.9) | 118 (2.0) | | |
17-18 years | 0 (0.0) | 118 (2.3) | | | Boys | 1 (0.9) | 161 (2.7) | | | Girls | 0 (0.0) | 76 (1.3) | |
| | Cocaine | All | 3 (1.4) | 439 (3.7) | | |
15-16 years | 2 (2.0) | 196 (3.3) | | |
17-18 years | 1 (0.9) | 242 (4.0) | | | Boys | 3 (1.4) | 247 (4.2) | | | Girls | 0 (0.0) | 192 (3.1) | |
| | Heroine | All | 1 (0.5) | 275 (2.3) | | |
15-16 years | 1 (0.9) | 150 (2.5) | | |
17-18 years | 0 (0.0) | 124 (2.1) | | | Boys | 1 (0.9) | 166 (2.8) | | | Girls | 0 (0.0) | 109 (1.8) | |
| | Drugs by injection with needle | All | 1 (0.5) | 212 (1.8) | | |
15-16 years | 1 (0.9) | 98 (1.6) | | |
17-18 years | 0 (0.0) | 113 (1.9) | | | Boys | 1 (0.9) | 142 (2.4) | | | Girls | 0 (0.0) | 70 (1.2) | |
| | GHB | All | 1 (0.5) | 154 (1.3) | | |
15-16 years | 1 (0.9) | 79 (1.3) | | |
17-18 years | 0 (0.0) | 74 (1.2) | | | Boys | 1 (0.9) | 142 (2.4) | | | Girls | 0 (0.0) | 70 (1.2) | |
| | Anabolic steroids | All | 2 (1.0) | 328 (2.7) | | |
15-16 years | 0 (0.0) | 143 (2.4) | | |
17-18 years | 2 (1.8) | 184 (3.1) | | | Boys | 2 (1.8) | 271 (4.6) | | | Girls | 0 (0.0) | 57 (0.9) | |
| | Relevin | All | 0 (0.0) | 157 (1.3) | | |
15-16 years | 0 (0.0) | 79 (1.3) | | |
17-18 years | 0 (0.0) | 77 (1.3) | | | Boys | 0 (0.0) | 111 (1.9) | | | Girls | 0 (0.0) | 46 (0.8) | |
|
|
